These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 32475049)

  • 21. Systemic lupus erythematosus and the risk of cardiovascular disease: results from the nurses' health study.
    Hak AE; Karlson EW; Feskanich D; Stampfer MJ; Costenbader KH
    Arthritis Rheum; 2009 Oct; 61(10):1396-402. PubMed ID: 19790130
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk of End-Stage Renal Disease in Patients With Systemic Lupus Erythematosus and Diabetes Mellitus: A Danish Nationwide Cohort Study.
    Hansen RB; Falasinnu T; Faurschou M; Jacobsen S; Simard JF
    Arthritis Care Res (Hoboken); 2023 Sep; 75(9):1871-1877. PubMed ID: 36705445
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of Diabetes Mellitus on the Risk of End-Stage Renal Disease in Patients with Systemic Lupus Erythematosus.
    Jiang MY; Hwang JC; Feng IJ
    Sci Rep; 2018 Apr; 8(1):6008. PubMed ID: 29662119
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Patients with systemic lupus erythematosus face a high risk of cardiovascular disease: A systematic review and Meta-analysis.
    Lu X; Wang Y; Zhang J; Pu D; Hu N; Luo J; An Q; He L
    Int Immunopharmacol; 2021 May; 94():107466. PubMed ID: 33636561
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparing the inflammatory profiles for incidence of diabetes mellitus and cardiovascular diseases: a prospective study exploring the 'common soil' hypothesis.
    Bao X; Borné Y; Johnson L; Muhammad IF; Persson M; Niu K; Engström G
    Cardiovasc Diabetol; 2018 Jun; 17(1):87. PubMed ID: 29895294
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cardiovascular risk in mild to moderately decreased glomerular filtration rate, diabetes and coronary heart disease in a southern European region.
    Gil-Terrón N; Cerain-Herrero MJ; Subirana I; Rodríguez-Latre LM; Cunillera-Puértolas O; Mestre-Ferrer J; Grau M; Dégano IR; Elosua R; Marrugat J; Ramos R; Baena-Díez JM; Salvador-González B
    Rev Esp Cardiol (Engl Ed); 2020 Mar; 73(3):212-218. PubMed ID: 30709697
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Personalizing cardiovascular risk prediction for patients with systemic lupus erythematosus.
    Choi MY; Guan H; Yoshida K; Paudel M; Kargere BA; Li D; Ellrodt J; Stevens E; Cai T; Weber BN; Everett BM; Costenbader KH
    Semin Arthritis Rheum; 2024 Aug; 67():152468. PubMed ID: 38788567
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increasing cardiovascular disease burden due to diabetes mellitus: the Framingham Heart Study.
    Fox CS; Coady S; Sorlie PD; D'Agostino RB; Pencina MJ; Vasan RS; Meigs JB; Levy D; Savage PJ
    Circulation; 2007 Mar; 115(12):1544-50. PubMed ID: 17353438
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence of conventional and lupus-specific risk factors for cardiovascular disease in patients with systemic lupus erythematosus: A case-control study.
    Bessant R; Duncan R; Ambler G; Swanton J; Isenberg DA; Gordon C; Rahman A
    Arthritis Rheum; 2006 Dec; 55(6):892-9. PubMed ID: 17139666
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stroke in systemic lupus erythematosus: a Swedish population-based cohort study.
    Arkema EV; Svenungsson E; Von Euler M; Sjöwall C; Simard JF
    Ann Rheum Dis; 2017 Sep; 76(9):1544-1549. PubMed ID: 28400384
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Brief Report: Trends in Hospitalizations Due to Acute Coronary Syndromes and Stroke in Patients With Systemic Lupus Erythematosus, 1996 to 2012.
    Tektonidou MG; Wang Z; Ward MM
    Arthritis Rheumatol; 2016 Nov; 68(11):2680-2685. PubMed ID: 27273732
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cutaneous lupus erythematosus and systemic lupus erythematosus are associated with clinically significant cardiovascular risk: a Danish nationwide cohort study.
    Hesselvig JH; Ahlehoff O; Dreyer L; Gislason G; Kofoed K
    Lupus; 2017 Jan; 26(1):48-53. PubMed ID: 27235406
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of Systemic Lupus Erythematosus on the Risk of Newly Diagnosed Hip Fracture: A General Population-Based Study.
    Li L; Xie H; Lu N; Esdaile JM; Aviña-Zubieta JA
    Arthritis Care Res (Hoboken); 2021 Feb; 73(2):259-265. PubMed ID: 31758639
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serious Infection Rates Among Children With Systemic Lupus Erythematosus Enrolled in Medicaid.
    Hiraki LT; Feldman CH; Marty FM; Winkelmayer WC; Guan H; Costenbader KH
    Arthritis Care Res (Hoboken); 2017 Nov; 69(11):1620-1626. PubMed ID: 28217919
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence and correlation of conventional and lupus-specific risk factors for cardiovascular disease in Chinese systemic lupus erythematosus patients.
    Yang L; Tao J; Tang X; Wang Y; He X; Xu G; Ren Y; Tu Y
    J Eur Acad Dermatol Venereol; 2012 Jan; 26(1):95-101. PubMed ID: 21851424
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Who Must We Target Now to Minimize Future Cardiovascular Events and Total Mortality?: Lessons From the Surveillance, Prevention and Management of Diabetes Mellitus (SUPREME-DM) Cohort Study.
    Desai JR; Vazquez-Benitez G; Xu Z; Schroeder EB; Karter AJ; Steiner JF; Nichols GA; Reynolds K; Xu S; Newton K; Pathak RD; Waitzfelder B; Lafata JE; Butler MG; Kirchner HL; Thomas A; O'Connor PJ;
    Circ Cardiovasc Qual Outcomes; 2015 Sep; 8(5):508-16. PubMed ID: 26307132
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Posttraumatic Stress Disorder and Risk of Systemic Lupus Erythematosus Among Medicaid Recipients.
    Case SM; Feldman CH; Guan H; Stevens E; Kubzansky LD; Koenen KC; Costenbader KH
    Arthritis Care Res (Hoboken); 2023 Jan; 75(1):174-179. PubMed ID: 34309239
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence of vascular disease in systemic lupus erythematosus compared with type-1 diabetes mellitus: a cross-sectional study of two cohorts.
    Koenig KF; Ribi C; Radosavac M; Zulewski H; Trendelenburg M;
    Lupus; 2015 Jan; 24(1):58-65. PubMed ID: 25182169
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of glucagon-like peptide-1 receptor agonists on major cardiovascular events in patients with Type 2 diabetes mellitus with or without established cardiovascular disease: a meta-analysis of randomized controlled trials.
    Marsico F; Paolillo S; Gargiulo P; Bruzzese D; Dell'Aversana S; Esposito I; Renga F; Esposito L; Marciano C; Dellegrottaglie S; Iesu I; Perrone Filardi P
    Eur Heart J; 2020 Sep; 41(35):3346-3358. PubMed ID: 32077924
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel gene variants associated with cardiovascular disease in systemic lupus erythematosus and rheumatoid arthritis.
    Leonard D; Svenungsson E; Dahlqvist J; Alexsson A; Ärlestig L; Taylor KE; Sandling JK; Bengtsson C; Frodlund M; Jönsen A; Eketjäll S; Jensen-Urstad K; Gunnarsson I; Sjöwall C; Bengtsson AA; Eloranta ML; Syvänen AC; Rantapää-Dahlqvist S; Criswell LA; Rönnblom L
    Ann Rheum Dis; 2018 Jul; 77(7):1063-1069. PubMed ID: 29514802
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.